PSMA & Newly-Diagnosed #ProstateCancer | MarkScholzMD #AlexScholz #PCRI

Imaging Alternatives For PSMA Negative #ProstateCancer Patients | #MarkScholzMD #AlexScholz #PCRISee more

Imaging Alternatives For PSMA Negative #ProstateCancer Patients | #MarkScholzMD #AlexScholz #PCRI

Treating Advanced #ProstateCancer with a High PSA | #MarkScholzMD #AlexScholz #PCRISee more

Treating Advanced #ProstateCancer with a High PSA | #MarkScholzMD #AlexScholz #PCRI

Can You Prevent #ProstateCancer? | Expert Oncologist #MarkScholzMD Answers | #AlexScholz #PCRISee more

Can You Prevent #ProstateCancer? | Expert Oncologist #MarkScholzMD Answers | #AlexScholz #PCRI

Micro-Ultrasound: New Developments in Prostate Imaging | #MarkScholzMD #AlexScholz #PCRISee more

Micro-Ultrasound: New Developments in Prostate Imaging | #MarkScholzMD #AlexScholz #PCRI

Recovering Testosterone After Hormone Therapy for #ProstateCancer | #MarkScholzMD #AlexScholz #PCRISee more

Recovering Testosterone After Hormone Therapy for #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

The Importance of #ProstateCancer Staging | #MarkScholzMD #AlexScholz #PCRISee more

The Importance of #ProstateCancer Staging | #MarkScholzMD #AlexScholz #PCRI

Treatments for #ProstateCancer Bone Metastasis | #MarkScholzMD #AlexScholz #PCRISee more

Treatments for #ProstateCancer Bone Metastasis | #MarkScholzMD #AlexScholz #PCRI

Treating #ProstateCancer In Younger Men | Age 40-60 | #MarkScholzMD #AlexScholz #PCRISee more

Treating #ProstateCancer In Younger Men | Age 40-60 | #MarkScholzMD #AlexScholz #PCRI

Treating Lymph Node #ProstateCancer Metastases | #MarkScholzMD #AlexScholz #PCRISee more

Treating Lymph Node #ProstateCancer Metastases | #MarkScholzMD #AlexScholz #PCRI

Treating Micro-Metastatic #ProstateCancer Disease | #MarkScholzMD #AlexScholz #PCRISee more

Treating Micro-Metastatic #ProstateCancer Disease | #MarkScholzMD #AlexScholz #PCRI

Debulking & Metastatic #ProstateCancer | #MarkScholzMD #AlexScholz #PCRISee more

Debulking & Metastatic #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI

New FDA Approved PARP Inhibitor: Talzenna (Talazoparib) & Xtandi | #markscholzmd #AlexScholz #pcriSee more

New FDA Approved PARP Inhibitor: Talzenna (Talazoparib) & Xtandi | #markscholzmd #AlexScholz #pcri

PSMA & Newly-Diagnosed #ProstateCancer | MarkScholzMD #AlexScholz #PCRISee more

PSMA & Newly-Diagnosed #ProstateCancer | MarkScholzMD #AlexScholz #PCRI

IMRT vs. SBRT & Reducing Radiation Toxicity | #MarkScholzMD #AlexScholz #PCRISee more

IMRT vs. SBRT & Reducing Radiation Toxicity | #MarkScholzMD #AlexScholz #PCRI

How Much Time Do You Have to Treat #ProstateCancer? | #MarkScholzMD #AlexScholz #PCRISee more

How Much Time Do You Have to Treat #ProstateCancer? | #MarkScholzMD #AlexScholz #PCRI

#ProstateCancer: Modern Imaging & Targeted Biopsies | #MarkScholzMD #AlexScholz #PCRISee more

#ProstateCancer: Modern Imaging & Targeted Biopsies | #MarkScholzMD #AlexScholz #PCRI

Lupron vs Eligard, Trelstar and Others | #MarkScholzMD #AlexScholz #PCRISee more

Lupron vs Eligard, Trelstar and Others | #MarkScholzMD #AlexScholz #PCRI

Does #ProstateCancer Tumor Size and Location Matter? | #MarkScholzMD #AlexScholz | #PCRISee more

Does #ProstateCancer Tumor Size and Location Matter? | #MarkScholzMD #AlexScholz | #PCRI

PSA After #ProstateCancer Surgery | #MarkScholzMD #AlexScholz | PCRISee more

PSA After #ProstateCancer Surgery | #MarkScholzMD #AlexScholz | PCRI

#ProstateCancer Diagnosis Over 80 Years Old | #MarkScholzMD #AlexScholz | #PCRISee more

#ProstateCancer Diagnosis Over 80 Years Old | #MarkScholzMD #AlexScholz | #PCRI

Actual